Spyre Therapeutics Inc (SYRE)

P/OCF Ratio

-37.69×

TTM · Retrieved:

SYRE logo

SYRE P/OCF Ratio

Current (TTM)-37.69×
SYRE Quarterly P/OCF Ratio (-74.68× → -107.65×)
High-resolution chart · PNG

SYRE p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-107.6503×
-69.058×
-55.1822×
-27.2797×
-19.5139×
-23.7277×
-29.431×
-50.8704×
-17.8723×
-47.3326×
-15.0499×
-1.5203×
-2.5908×
-1.5502×
-1.6211×
-3.2883×
-2.009×
-5.7797×
-12.1672×
-30.7662×
219.4035×
-26.6045×
-26.5546×
-25.1645×
-25.2259×
-7.1096×
-15.2498×
-14.6999×
-13.711×
-14.683×
-25.9208×
-24.4386×
-24.0971×
-21.537×
-14.5654×
-10.98×
-9.1449×
-18.3312×
-11.5655×
-14.5644×
-12.3557×
-28.0014×
-134.0569×
-30.7439×
-30.393×
-47.1869×
-41.2305×
-55.5726×
-82.2858×
-74.6769×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.